To stay up to date with our development, please subscribe to our press releases.
Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ENTYVIO® (vedolizumab) to achieve corticosteroid-free (CSF) disease clearance ...
Sobi® today announced that seven abstracts on Aspaveli/Empaveli (pegcetacoplan) have been accepted for presentation at the American Society of Nephrology (ASN) Kidney Week 2026, taking place from ...
When my 14-year-old son Khalif came home from school wanting to help a nonprofit, I never imagined it would end up helping our family just two years later. We joined the Rays of Hope Walk & Run Toward ...
Researchers at EPFL's Laboratory of Microbiology and Microtechnology uncovered the molecular mechanism of a UTI drug approved in Switzerland for over two decades. OM-89, marketed as Uro-Vaxom®, is an ...
“Many people worry that a recurrence is entirely out of their control,” says Elisabeth Heath, MD, chair of the department of oncology at Mayo Clinic in Rochester, Minnesota. But while no lifestyle ...
Interim analysis shows goals were met for recurrence and preventing cancer spread Moderna spikes as much as 160%; Merck jumps 12% Barclays estimates therapy could reach about $3 billion in melanoma ...
GEMINI-BREAST: Evaluating minimal residual disease (MRD) through longitudinal circulating tumor DNA (ctDNA) profiling in breast malignancies. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
The specific mix of bacteria living in a person's gut can predict the chances that melanoma will recur after surgery and immunotherapy, which helps immune cells target cancer cells. This is according ...
A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...
The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results